Diversified Healthcare Trust (DHC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Feb, 2026Company highlights and outlook
Portfolio valued at $6.3 billion, spanning 33 states and Washington, D.C., with 298 healthcare properties and ~25,000 senior living units.
Delivered 113% total shareholder return in 2025, ranking #1 among U.S. listed REITs.
Completed transition of 116 SHOP communities to seven third-party operators, improving occupancy and NOI.
SHOP occupancy rose 160 bps to 81.6% in 2025, with a 45.2% increase in SHOP NOI.
Leased 418,000 sq. ft. in Medical Office/Life Science at 12.4% higher rents than prior leases.
Financial performance and guidance
2026 guidance: Adjusted EBITDAre $290M–$305M, Normalized FFO $125M–$140M, NOI $297M–$313M.
SHOP NOI expected between $175M–$185M; MOB/LS NOI $94M–$98M; NNN NOI $28M–$30M.
Recurring CapEx projected at $100M–$115M; occupancy growth of ~300 bps and revenue growth of ~8%.
No acquisitions planned; only 13 SHOP dispositions expected in 2026.
Strategic initiatives and capital recycling
Sold $605M in non-core properties in 2025, with $23M more expected in 1Q26.
Raised $868M in debt and established a $150M undrawn revolving credit facility.
Fully redeemed 2026 zero coupon notes, releasing $850M in collateral and extending debt maturity to 2028.
Capital recycling focused on deleveraging and portfolio quality improvement.
Latest events from Diversified Healthcare Trust
- Updated sustainability metrics and climate risk strategies underscore ongoing ESG leadership.DHC
Proxy filing25 Mar 2026 - Proxy covers trustee elections, say-on-pay, auditor ratification, and robust ESG and governance practices.DHC
Proxy filing19 Mar 2026 - Trustee elections, executive pay, and auditor ratification headline the June 2026 meeting.DHC
Proxy filing19 Mar 2026 - Record NOI growth, margin expansion, and debt reduction drive strong shareholder returns.DHC
Q4 202524 Feb 2026 - Q1 2025 delivered 4.3% revenue growth, narrowed net loss, and strong SHOP segment gains.DHC
Q1 20255 Feb 2026 - Q3 2025 revenue up, SHOP improved, but net loss rose on impairments and transitions.DHC
Q3 20255 Feb 2026 - Q4 revenue up 5%, SHOP NOI up 56%, and a $7.2B portfolio supports debt reduction.DHC
Q4 20245 Feb 2026 - SHOP segment drives NOI growth, but net loss widens amid asset sales and cost pressures.DHC
Q3 20245 Feb 2026 - Q2 2024 delivered strong SHOP NOI growth and higher revenues despite a wider net loss.DHC
Q2 20245 Feb 2026